These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33868574)

  • 1. Redox Enzymes of the Thioredoxin Family as Potential and Novel Markers in Pemphigus.
    Sliwiak P; Folwarczny E; Didona D; Fink S; Wiegand C; Hanschmann EM; Hertl M; Hudemann C
    Oxid Med Cell Longev; 2021; 2021():6672693. PubMed ID: 33868574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new ex vivo human oral mucosa model reveals that p38MAPK inhibition is not effective in preventing autoantibody-induced mucosal blistering in pemphigus.
    Egu DT; Sigmund AM; Schmidt E; Spindler V; Walter E; Waschke J
    Br J Dermatol; 2020 Apr; 182(4):987-994. PubMed ID: 31218663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutaredoxin 2 Reduces Asthma-Like Acute Airway Inflammation in Mice.
    Hanschmann EM; Berndt C; Hecker C; Garn H; Bertrams W; Lillig CH; Hudemann C
    Front Immunol; 2020; 11():561724. PubMed ID: 33224135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox atlas of the mouse. Immunohistochemical detection of glutaredoxin-, peroxiredoxin-, and thioredoxin-family proteins in various tissues of the laboratory mouse.
    Godoy JR; Funke M; Ackermann W; Haunhorst P; Oesteritz S; Capani F; Elsässer HP; Lillig CH
    Biochim Biophys Acta; 2011 Jan; 1810(1):2-92. PubMed ID: 20682242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Src and Cortactin in Pemphigus Skin Blistering.
    Kugelmann D; Rötzer V; Walter E; Egu DT; Fuchs MT; Vielmuth F; Vargas-Robles H; Schnoor M; Hertl M; Eming R; Rottner K; Schmidt A; Spindler V; Waschke J
    Front Immunol; 2019; 10():626. PubMed ID: 31024527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction.
    Heupel WM; Zillikens D; Drenckhahn D; Waschke J
    J Immunol; 2008 Aug; 181(3):1825-34. PubMed ID: 18641320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical Role of the Neonatal Fc Receptor (FcRn) in the Pathogenic Action of Antimitochondrial Autoantibodies Synergizing with Anti-desmoglein Autoantibodies in Pemphigus Vulgaris.
    Chen Y; Chernyavsky A; Webber RJ; Grando SA; Wang PH
    J Biol Chem; 2015 Sep; 290(39):23826-37. PubMed ID: 26260795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism-based proteomic screening identifies targets of thioredoxin-like proteins.
    Nakao LS; Everley RA; Marino SM; Lo SM; de Souza LE; Gygi SP; Gladyshev VN
    J Biol Chem; 2015 Feb; 290(9):5685-95. PubMed ID: 25561728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice.
    Hofrichter M; Dworschak J; Emtenani S; Langenhan J; Weiß F; Komorowski L; Zillikens D; Stöcker W; Probst C; Schmidt E; Goletz S
    Front Immunol; 2018; 9():1935. PubMed ID: 30233569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of p38MAPK signalling prevents epidermal blistering and alterations of desmosome structure induced by pemphigus autoantibodies in human epidermis.
    Egu DT; Walter E; Spindler V; Waschke J
    Br J Dermatol; 2017 Dec; 177(6):1612-1618. PubMed ID: 28600798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Rho A activity causes pemphigus skin blistering.
    Waschke J; Spindler V; Bruggeman P; Zillikens D; Schmidt G; Drenckhahn D
    J Cell Biol; 2006 Dec; 175(5):721-7. PubMed ID: 17130286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum from pemphigus vulgaris reduces desmoglein 3 half-life and perturbs its de novo assembly to desmosomal sites in cultured keratinocytes.
    Cirillo N; Femiano F; Gombos F; Lanza A
    FEBS Lett; 2006 May; 580(13):3276-81. PubMed ID: 16698018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response in pemphigus and beyond: progresses and emerging concepts.
    Di Zenzo G; Amber KT; Sayar BS; Müller EJ; Borradori L
    Semin Immunopathol; 2016 Jan; 38(1):57-74. PubMed ID: 26597100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioredoxin and glutaredoxin system proteins-immunolocalization in the rat central nervous system.
    Aon-Bertolino ML; Romero JI; Galeano P; Holubiec M; Badorrey MS; Saraceno GE; Hanschmann EM; Lillig CH; Capani F
    Biochim Biophys Acta; 2011 Jan; 1810(1):93-110. PubMed ID: 20620191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus.
    Nishifuji K; Olivry T; Ishii K; Iwasaki T; Amagai M
    Vet Immunol Immunopathol; 2007 Jun; 117(3-4):209-21. PubMed ID: 17350107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keratin Retraction and Desmoglein3 Internalization Independently Contribute to Autoantibody-Induced Cell Dissociation in Pemphigus Vulgaris.
    Schlögl E; Radeva MY; Vielmuth F; Schinner C; Waschke J; Spindler V
    Front Immunol; 2018; 9():858. PubMed ID: 29922278
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased oxidative stress in pemphigus vulgaris is related to disease activity and HLA-association.
    Shah AA; Dey-Rao R; Seiffert-Sinha K; Sinha AA
    Autoimmunity; 2016 Jun; 49(4):248-57. PubMed ID: 26911801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathophysiological significance of nondesmoglein targets of pemphigus autoimmunity. Development of antibodies against keratinocyte cholinergic receptors in patients with pemphigus vulgaris and pemphigus foliaceus.
    Vu TN; Lee TX; Ndoye A; Shultz LD; Pittelkow MR; Dahl MV; Lynch PJ; Grando SA
    Arch Dermatol; 1998 Aug; 134(8):971-80. PubMed ID: 9722727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The desmosome and hemidesmosome in cutaneous autoimmunity.
    Lin MS; Mascaró JM; Liu Z; España A; Diaz LA
    Clin Exp Immunol; 1997 Jan; 107 Suppl 1():9-15. PubMed ID: 9020929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pemphigus: Current and Future Therapeutic Strategies.
    Didona D; Maglie R; Eming R; Hertl M
    Front Immunol; 2019; 10():1418. PubMed ID: 31293582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.